Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M® for Military Field Use
July 31 2024 - 8:00AM
Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the
“Company”), an artificial intelligence (AI) company
focused on medical diagnostics for faster and more accurate
treatment decisions in wound care, today announced continuing
progress in the development of DeepView SnapShot® M, a
handheld diagnostic tool targeted for use in battlefield burn
assessment that is based on the Company’s AI-driven DeepView™
System platform.
Burn wounds account for a significant portion of
combat-related injuries, often resulting from explosive device
detonation, penetrating injuries or other trauma. However, the
availability of burn wound assessment and treatment expertise is
often lacking in a battlefield setting.
DeepView SnapShot M® is designed to be an
integral part of the battlefield triage process by providing a
quick and accurate wound assessment so that those with more severe
burn injuries can be prioritized for evacuation. Spectral AI’s
research and development team has continued to refine the device
and is developing features necessary for military use. Among these
refinements is the miniaturization of the device’s five cameras
which have retained their ability to capture the same depth of
wavelength as the Company’s cart-based DeepView™ System with no
trade off in tolerance or accuracy. Image capture time remains less
than one second and the device’s cameras were optimized to reduce
unwanted light, a challenge that is present when imaging patients
in a field-based setting rather than a clinically controlled
environment.
“Successful burn wound management is essential
to patient survival, and this need is magnified in the battlefield
setting,” said Peter M. Carlson, Chief Executive Officer of
Spectral AI. “Developing technology that can support our nation’s
armed forces is a matter of much personal and professional pride
for all of us at Spectral AI, and we are honored to be a part of a
select group of companies pursuing that objective. We are
continuing to advance the evolution of this proprietary AI-driven
burn wound assessment technology, and believe that its potential
applications can extend beyond military use to serve our first
responders and other healthcare providers.”
The Company also announced that an abstract
titled, “Advancing Combat Burn Assessment of DeepView’s Handheld
Device for Military Field Use” has been accepted for a poster
presentation at the upcoming 2024 Military Health System Research
Symposium (MHSRS) being held on August 26-29, 2024.
The Department of Defense’s foremost scientific
meeting, the MHSRS is a joint symposium that provides a
collaborative environment for presenting new scientific knowledge
resulting from military-unique research and development.
About Spectral AI Spectral
AI, Inc. is a Dallas-based predictive AI company focused on medical
diagnostics for faster and more accurate treatment decisions in
wound care, with initial applications involving patients with burns
and diabetic foot ulcers. The Company is working to revolutionize
the management of wound care by “Seeing the Unknown®” with its
DeepView™ System. The DeepView™ System is a predictive device
that offers clinicians an objective and immediate assessment of a
wound’s healing potential prior to treatment or other medical
intervention. With algorithm-driven results and a goal to change
the current standard of care, the DeepView™ System is expected to
provide faster and more accurate treatment insight towards value
care by improving patient outcomes and reducing healthcare costs.
For more information about the DeepView™ System, visit
www.spectral-ai.com.
Forward Looking
Statements Certain statements made in this release
are “forward looking statements” within the meaning of the “safe
harbor” provisions of the United States Private Securities
Litigation Reform Act of 1995, including statements regarding the
Company’s strategy, plans, objectives, initiatives and financial
outlook. When used in this press release, the words “estimates,”
“projected,” “expects,” “anticipates,” “forecasts,” “plans,”
“intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,”
“propose” and variations of these words or similar expressions (or
the negative versions of such words or expressions) are intended to
identify forward-looking statements.
These forward-looking statements are not
guarantees of future performance, conditions or results, and
involve a number of known and unknown risks, uncertainties,
assumptions and other important factors, many of which are outside
Company’s control, that could cause actual results or outcomes to
differ materially from those discussed in the forward-looking
statements. As such, readers are cautioned not to place undue
reliance on any forward-looking statements.
Investors should carefully consider the
foregoing factors and the other risks and uncertainties described
in the “Risk Factors” sections of the Company’s filings with the
SEC, including the Registration Statement and the other documents
filed by the Company. These filings identify and address other
important risks and uncertainties that could cause actual events
and results to differ materially from those contained in the
forward-looking statements.
Investors: The Equity
Group Devin Sullivan Managing
Director dsullivan@equityny.com
Conor Rodriguez Analyst crodriguez@equityny.com
Spectral AI (NASDAQ:MDAI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Spectral AI (NASDAQ:MDAI)
Historical Stock Chart
From Oct 2023 to Oct 2024